WINGORA

This brand name is authorized in Nigeria.

Active ingredients

The drug WINGORA contains one active pharmaceutical ingredient (API):

1	Sildenafil UNII BW9B0ZE037 - SILDENAFIL CITRATE
	Sildenafil is a potent and selective inhibitor of cyclic guanosine monophosphate (cGMP) specific phosphodiesterase type 5 (PDE5), the enzyme that is responsible for degradation of cGMP. Apart from the presence of this enzyme in the corpus cavernosum of the penis, PDE5 is also present in the pulmonary vasculature. Sildenafil, therefore, increases cGMP within pulmonary vascular smooth muscle cells resulting in relaxation.
	Read more about Sildenafil

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-6595	Tablet	Wingora 50 Tablets TAB 50 mg	WINGORA 50 TABLETS B4-6595 WINGORA 50 TABLETS SILDENAFIL CITRATE 50MG, TITANIUM DIOXIDE POM 1 ADLER PRODUCTS LIMITED, ODUYEMI STREET, IKEJA LAGOS VITABIOTICS LTD, 1 APSLEY WAY, LONDON NW27 HF, ENGLAND., Nigeria 23/02/2023 22/02/2028	23/02/2023
B4-6596	Tablet	Wingora 100 Tablets TAB 100 mg	WINGORA 100 TABLETS B4-6596 WINGORA 100 TABLETS SILDENAFIL CITRATE 100MG, TITANIUM DIOXIDE Prescription Only Medicine (POM) ADLER PRODUCTS LIMITED, ODUYEMI STREET, IKEJA LAGOS VITABIOTICS LTD, 1 APSLEY WAY, LONDON NW27 HF, ENGLAND., Nigeria 23/02/2023 22/02/2028	23/02/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
G04BE03	Sildenafil	G Genito urinary system and sex hormones → G04 Urologicals → G04B Other urologicals, incl. antispasmodics → G04BE Drugs used in erectile dysfunction
Discover more medicines within G04BE03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-6595, B4-6596